Medical technologies
-
Johnson & Johnson MedTech to Highlight Latest Advancements in Heart Disease Treatment with Impella at ACC.25
Impella heart pump upgraded to Class 2a in ACC/AHA treatment guideline for cardiogenic shock secondary to STEMI -
Johnson & Johnson MedTech Launches the DUALTO™ Energy System for Use Across Surgical Treatment Approaches
The DUALTO™ electrosurgical generator is designed to offer a simplified user experience, access to Polyphonic™ Fleet digital device management, and flexible application of monopolar, bipolar, ultrasonic, and advanced bipolar energy devices for open and minimally invasive surgery DUALTO will be showcased at the Association of periOperative Registered Nurses Global Surgical Conference & Expo on April 5-8, 2025 The DUALTO Energy System recently received 510(k) clearance by the U.S. Food & Drug Administration1 -
Johnson & Johnson MedTech Announces Clearance of MONARCHTM QUEST for Enhanced Robotic-Assisted Bronchoscopy
Next-generation NVIDIA-powered AI navigation software elevates MONARCHTM Platform for Robotically Assisted Bronchoscopy -
Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025
Building on last year’s momentum of 18 FDA 510(k) Clearances and 45 global product launches, the company accelerates innovation across joint reconstruction, trauma, spine, and more -
Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions
Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease -
Johnson & Johnson MedTech Celebrates Inaugural National Heart Recovery Awareness Day
Impella patients share stories of heart recovery at reunions, events across the country Launch of Boston’s first hands-only CPR kiosk with American Heart Association -
Johnson & Johnson to Resume U.S. VARIPULSE™ Cases
Investigation found that VARIPULSE™ devices operate as intended Cases being performed in U.S. External Evaluation to resume and Instructions for Use to be updated -
Johnson & Johnson MedTech Launches CEREGLIDE™ 92 Catheter System for Acute Ischemic Stroke
Next-generation .092” catheter now available in U.S. -
Johnson & Johnson MedTech Announces CE Mark Approval for Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter
The Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter offers electrophysiologists the ability to switch between radiofrequency and pulsed field energy in a single, fully integrated catheter CE Mark supported by the SmartfIRE study on the Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter for the treatment of paroxysmal atrial fibrillation (AFib) Additional milestones announced include complete enrollment of the SmartPulse and PulseSmart trials